Literature DB >> 14628137

The Grummons face mask as an early treatment modality within a class III therapy concept.

Michael Hegmann1, Anne-Kathrin Rüther.   

Abstract

BACKGROUND AND AIM: An underdeveloped maxillary complex is a major cause of the problems underlying skeletal Class III cases. The efficiency of early orthodontic therapy is shown with reference to a treatment method acting primarily on the maxillary complex. PATIENTS AND
METHOD: The collective comprised 21 patients whose orthodontic therapy at the age of 5 to 9 years was invariably started with a palatal expander. This was followed by further development of the nasomaxillary complex, using a Grummons face mask for a period ranging from 3 to 15 months. With reference to findings from plaster casts and lateral cephalograms, the efficiency of early treatment as an important part of the overall therapy concept was evaluated.
RESULTS: The mean improvement in anterior overbite was 3.4 mm. The lateral cephalograms revealed a marked improvement in the distance between the upper first molars and the pterygoid vertical (+ 4.1 mm), in the convexity of A (+ 2.2 mm), and in the SNA angle (+ 2.3 degrees).
CONCLUSION: Early treatment combining rapid maxillary expansion and Grummons face mask resulted in a decisive improvement in the sagittal-basal relations.

Entities:  

Mesh:

Year:  2003        PMID: 14628137     DOI: 10.1007/s00056-003-0245-3

Source DB:  PubMed          Journal:  J Orofac Orthop        ISSN: 1434-5293            Impact factor:   1.938


  2 in total

1.  Treatment of maxillary deficiency by miniplates: a case report.

Authors:  Rahman Showkatbakhsh; Abdolreza Jamilian; Mohammad Behnaz
Journal:  ISRN Surg       Date:  2011-05-10

2.  Early Class III treatment with Hybrid-Hyrax - Facemask in comparison to Hybrid-Hyrax-Mentoplate - skeletal and dental outcomes.

Authors:  Jan H Willmann; Manuel Nienkemper; Nour Eldin Tarraf; Benedict Wilmes; Dieter Drescher
Journal:  Prog Orthod       Date:  2018-10-22       Impact factor: 2.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.